NIH-funded study finds hepatitis C treatment gap for individuals with alcohol use disorder

A new study supported by the National Institutes of Health shows that individuals with alcohol use disorder (AUD) are less likely to receive antivirals for hepatitis C, despite current guidelines recommending antiviral treatment regardless of alcohol use. Direct-acting antiviral treatment is highly effective at reducing serious illness and death among individuals with hepatitis C virusA new study supported by the National Institutes of Health shows that individuals with alcohol use disorder (AUD) are less likely to receive antivirals for hepatitis C, despite current guidelines recommending antiviral treatment regardless of alcohol use. Direct-acting antiviral treatment is highly effective at reducing serious illness and death among individuals with hepatitis C virus » The FINANCIAL Health&Beauty

Related Keywords

New Haven ,Connecticut ,United States ,Yale University ,Georgef Koob ,Lamiay Haque , ,Veterans Health Administration ,Yale School Of Medicine ,National Institutes Of Health ,National Institutes ,Yale Clinic ,Addiction Treatment ,Digestive Diseases ,Yale School ,Veterans Birth Cohort ,Health Amp Beauty ,